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Improvement in hospital Quality of Care (QoC)
after the introduction of rotavirus vaccination:
An evaluation study in Belgium
B Standaert1,*, A Alwan2, D Strens3, M Raes4, and MJ Postma5
1GSK Vaccines; Wavre, Belgium; 2MedStat; Antwerp, Belgium; 3Realidad; Grimbergen, Belgium; 4Jessa Hospital; Hasselt, Belgium; 5University of Groningen; Groningen,
The Netherlands
Keywords: bed management, hospital, pediatric, Quality of care, rotavirus vaccination, staff management
Abbreviations: QoC, quality of care; EFA, explanatory factor analysis; RSV, respiratory syncytial virus; AGE, acute gastro-enteritis;
US, United States; BDOR, bed-day occupancy; BTOR, bed-day turnover; UnPln, unplanned readmissions; FTE(s), full-time equiva-
lent staff per day; OTW, overtime hours worked per day; RVGE, rotavirus gastro-enteritis; RVNR, RVGE nosocomial infection rate;
RVDR, RVGE specific death rate; HR, Hospitalization rate; SLT, Staff Leave Time; SR, Staff replacement per day
During each winter period hospital emergency rooms and pediatric wards are often overwhelmed by high patient
inﬂux with infectious diseases leading to chaotic conditions with poor quality of care (QoC) delivery as a consequence.
The conditions could be improved if we were able to better control the inﬂux by introducing for instance better
prevention strategies against some of the most frequent infectious diseases. New prevention strategies using
vaccination against rotavirus infection were introduced in Belgium in November 2006. We developed a measure of
hospital QoC suitable for assessing the impact of pediatric rotavirus vaccination. The study is retrospective collecting
routine data on bed and staff management in one pediatric hospital in Belgium. The data were divided in pre- and
post-vaccination periods during rotavirus-epidemic and non-epidemic periods. The scores were constructed using
Explanatory Factor Analysis (EFA). All patients enrolled were admitted to the pediatric ward over the period from 1
January 2004 to 31 December 2009. The results of the epidemic period indicated that bed-day occupancy, bed-day
turnover and unplanned readmissions for acute gastroenteritis were lower in the post-vaccination compared with the
pre-vaccination periods. The QoC scores were therefore signiﬁcantly lower (indicating improved QoC) after the
introduction of rotavirus vaccination, compared with pre-vaccination. The data suggests that the reduction in
the winter peak of rotavirus-related hospitalizations after the introduction of the vaccine reduces pressure on hospital
resources and improves the quality of hospital care. The ﬁndings should be further tested in similar settings.
Introduction
Rotavirus disease places a high demand on European health-
care systems, accounting for 56.2% of hospitalizations and
32.8% of emergency department visits for community-acquired
gastroenteritis during the winter epidemic seasons in children
aged <5 years.1 The seasonal rotavirus peak coincides with other
pediatric infections, such as respiratory syncytial virus (RSV),
influenza, pneumococcal disease, and other causes of acute gas-
tro-enteritis (AGE).2,3 Each winter, those infections cause a high
influx of children with communicable diseases into pediatric hos-
pital wards and emergency rooms.
These winter increases in hospitalizations for infectious dis-
eases in young children place a heavy burden on the delivery of
medical care.4,5 Overcrowding and excess workload in hospital
care is recognized as a serious problem for patients and staff.6,7
High patient-to-nurse ratios are related to unfavourable patient
outcomes and increased self-reports of staff burnout and job dis-
satisfaction.8 In addition to staff stress, the influx of infectious
disease cases may result in wards crowded over capacity, facilitat-
ing pathogen transmission and increasing nosocomial infections.9
This has been documented by epidemiological data, but the con-
sequences have not been fully investigated.10,11 Overcrowding
leads to high turnovers, with consequent potential for premature
discharge and high readmission rates.12-15 Over-stressed condi-
tions for staff may be associated with high sickness rates requiring
recruitment of temporary personnel, which in turn may be asso-
ciated with a risk of incorrect diagnosis and/or treatment. Thus,
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the seasonal influx of patients with communicable diseases during
a short time risks a cascade of sequential problems each winter.
Rotavirus vaccination was introduced in 2006 and offers
the potential for better control of the influx of infectious dis-
ease cases.16 Rotavirus vaccination in countries with estab-
lished vaccination programmes has consistently and
significantly reduced the incidence of rotavirus gastroenteritis
(RVGE) and associated hospitalizations, emergency depart-
ment visits and outpatient/physician office visits in the United
States (US), Europe and Australia.17-20
Belgium introduced rotavirus vaccination in November 2006,
with an uptake of 85% in the first year21 and 89% in the second
year.22 This high vaccine uptake is maintained throughout subse-
quent years where parents are asked for a co-payment of the vac-
cine of 11.6€ per dose.23 We have previously investigated the
change in winter pediatric hospitalizations from before to after
the introduction of rotavirus vaccination.22 By reducing the sea-
sonal influx of urgent RVGE cases into pediatric hospitals, the
vaccine could help to reduce the winter pressure on healthcare
resources and staff, offering potential wider benefits beyond
reduced healthcare costs and quality-of-life gains in improving
hospital quality of care (QoC). Such benefits would accrue to
patients and their families, staff and hospital managers. Patients,
who at present may be exposed to overcrowded hospitals with
staff operating under stressful conditions, could benefit from bet-
ter care provided by a less pressured service. Staff could benefit
from reduced work stress and thus better conditions for optimal
delivery of care, and could be less prone to infections. Health
authorities and management may benefit from more efficient
overall operation of the healthcare system, and will be better able
to maintain a high quality of hospital care throughout the year.
Can these additional potential benefits of rotavirus vaccina-
tion on QoC be measured, and could such a measure be used as
a benchmark for assessing the value of a new vaccine to hospital
care? The objective was to obtain a daily QoC score based on eas-
ily accessible variables that reflect the management of hospital
beds and staff. The score should indicate when care management
is at risk for a quality drop potentially affecting patients and care-
givers, and should be able to measure the impact of a vaccine
introduction. The following hypothesis was therefore tested. The
average daily QoC score in hospital management during winter
epidemic seasons is significantly/relevantly worse in pre-vaccina-
tion compared with post-vaccination periods with a large score
difference among the AGE population, a moderate score differ-





Testing for rotavirus started on 1 June 2005. The percentage
of rotavirus-positive tests in the winter decreased from 56.9%
(165/290) pre-vaccination to 23.0% (48/209) post-vaccination
(Table 1).
Bed management variables
Table 2 shows the results for bed-day occupancy (BDOR),
bed-day turnover (BTOR) and unplanned readmissions (UnPln).
During the observation period (1st of January 2004 to 31st of
December 2009) the total number of bed-days occupied in the
pediatric ward with 34 beds was 56,451 days (76%), of which
25,973 days (46%) were due to infectious diseases. Of these,
7,697 days (29.6%) were due to AGE. During the winter the
mean number of occupied beds per day for AGE (BDOR) was
much higher pre-vaccination than post-vaccination (7.52 bed-
days vs. 4.47 bed-days, respectively). The AGE BTOR rate and
AGE UnPln rate were also higher pre-vaccination than post-vac-
cination (0.048 versus 0.028 for BTOR and 0.56 vs. 0.16 for
UnPln, respectively).
Table 1. Number of rotavirus tests and rotavirus-positive tests by study
period during the winter
RV tests Pre-vaccination (2005–2006) Post-vaccination (2007–2009)
Positive (%) 165 (56.9%) 48 (23.0%)
Total 290 209
RV, rotaviru
Table 2. Bed management variables (2004–2009) for overall, infection-only,
and AGE patient groups by study period during the winter
Study period Value Overall Infection-only AGE
Occupied beds per day (BDOR)
Pre-vaccination Mean 30.59 16.96 7.52
N 271 271 271
SD 7.05 4.29 3.51
Sum 8,289 4,595 2,039
Post-vaccination Mean 28.89 14.80 4.47
N 361 361 361
SD 7.25 3.95 2.19
Sum 7,828 4,010 1,212
Bed turnover rate per day (BTOR)
Pre-vaccination Mean 0.253 0.079 0.048
N 271 271 271
SD 0.132 0.052 0.041
Sum 69 21 13
Post-vaccination Mean 0.284 0.065 0.028
N 361 361 361
SD 0.143 0.048 0.031
Sum 77 18 8
Unplanned readmission rate per day (UnPln)
Pre-vaccination Mean 0.93 0.76 0.56
N 271 271 271
Cases 48 36 29
SD 0.908 0.880 0.691
Sum 253 207 152
Post-vaccination Mean 0.38 0.29 0.16
N 361 361 271
Cases 25 19 9
SD 0.685 0.529 0.404
Sum 136 106 43
AGE, acute gastroenteritis; SD, standard deviation; N, Number of days






























Surprisingly, the mean number of full-time equivalent staff
per day (FTEs) and overtime hours (OTW) were higher in post-
than pre-vaccination (Table 3, 14.468 FTEs versus 14.945 FTEs
and 6.95 h vs. 7.55 h OTW). However, the minimum numbers
were much lower in post-vaccination periods (9.1 FTEs versus
6.9 FTEs and 3 h vs. 0 h for OTW). It was not possible to split
FTEs and OTW by patient group. Only a few days had overtime
hours. Pre-vaccination, the number of days with overtime hours
was 38/271 (14%), compared with 57/361 [16%] post-vaccina-
tion. Table 4 shows data on staff sick leave (SLT). The pre-vacci-
nation period had higher average and maximum values for sick
leave than the post-vaccination period (5.25 h versus 4.37 h).
Analytical results
Table 5 shows average Factor 1 (bed management score),
Factor 2 (staff management score) and overall QoC scores
(Factor 1 C Factor2) pre- and post-vaccination. QoC scores
were significantly lower (improved QoC) post-vaccination
than pre-vaccination in all 3 groups (AGE, Infection only,
Overall). The largest difference was in the AGE group, as
expected. It may be surprising that the QoC improvement
post-vaccination in the infection-only group was not larger
than in the overall group. This may be because the AGE group
comprised a large proportion of the infection-only group, and
there were relatively few non-AGE infections to benefit from
improvements in time and bed-space. This is not the case
when the overall pediatric ward is considered.
Figure 1 compares the daily Factor 2 (staff management)
scores during the winter of 2006 and 2008 as an example.
In 2006 (pre-vaccination) there was a period of stress, indicated
by high Factor 2 scores, with no equivalent in 2008 (post-vacci-
nation). Figure 2 shows as another example of the impact of
the vaccine, the absolute number of bed-days occupied per
month in 2005 (1 year pre-vaccination) and 2009 (2 years
post-vaccination). Post-vaccination, BDOR stayed below the
ideal threshold throughout the winter rotavirus season (Janu-
ary–March), whereas pre-vaccination the BDOR was above this
threshold for several months. The increase in November–
December in both years is partly explained by the hospitaliza-
tion of RSV cases.
Discussion
Introducing a new vaccine with an immediate high uptake
(>85% coverage) and an explicit focus on reducing hospitaliza-
tions during epidemic seasons into an established healthcare sys-
tem would be expected to affect hospital management.24,25
Overcrowding as indicated by excess BDOR has been associated
with increased hospital infections and patient mortality,26-28 and
exposure to BDOR of >10% in excess of the recommended limit
of 85% for >6 months has been associated with antidepressant
treatment in hospital staff.29 Overcrowding typically occurs in the
winter, when influenza, RSV, pneumococcal disease and rotavirus
all circulate together, and can be exacerbated by rapid pathogen
spread within the hospital causing high rates of nosocomial infec-
tion. However, although the problem of winter pressure is familiar
to hospital staff, until now there has been no method to quantify
that phenomenon into one single measure. The present study is a
first attempt to develop a single QoC score that can quantify stress
in healthcare services and can assess the impact of interventions,
such as rotavirus vaccine introduction, on service stress.
As this was a retrospective analysis, we used data that were
already available. This should allow replication of this analysis
in other hospital settings collecting similar data which is the
Table 3. Staff management variables (2004–2009) for overall study period
during the winter
Study period N Sum Mean SD Maximum Minimum
Staff numbers per day (FTEs)
Pre-vaccination 271 3920.9 14.468 3.064 21.3 9.1
Post-vaccination 361 5395.3 14.945 3.634 22.9 6.9
Overtime hours worked per day (OTW)
Pre-vaccination 38 264 6.95 2.770 14 3
Post-vaccination 57 431 7.55 2.608 16 0
FTE, full-time equivalent; SD, standard deviation; N, Number of days.
Table 4. Staff sick leave by season and study period
Study period Value Sick leave, hours Sick leave, persons Sick leave, FTE
Pre-vaccination N 271 271 271
Sum 1423.28 308 187.274
Mean 5.252 1.14 0.691
SD 5.990 0.95 0.788
Maximum 25.47 4 3.351
Minimum 0.00 0 0.000
Post-vaccination N 361 361 361
Sum 1579.33 311 207.807
Mean 4.375 0.86 .575
SD 5.148 0.858 .677
Maximum 20.90 4 2.750
Minimum 0.00 0 0.000
FTE, full-time equivalent; SD, standard deviation; N, Number of days.





























case for bed day management variables but could be more dif-
ficult for staff management variables that most often are not
fully electronically available over a long enough period during
pre-vaccination or before 2006 in Belgium. Overcrowding and
its adverse effects on staff stress should be visible in measures
of bed management and staff management, so we concentrated
on variables in these areas. Some of these variables should be
correlated, e.g. when BDOR is high, BTOR is also likely to
be high, which in turn increases the risk of unplanned read-
mission. The technique of Explanatory Factor Analysis (EFA)
allows identification of links between the variables and the
integration of several variables into a new measure. In the
present study, we pre-defined the number of Factors we
wanted to work with, one on bed management and one on
staff management, to facilitate the construction of an overall
QoC score with the right weighting values for each variable in
the EFA equation. As expected, the difference in winter QoC
scores pre- and post-vaccination was highest among AGE
patients. Notably, there was also a substantial difference for
the overall group. This indicates that improved QoC after
introduction of rotavirus vaccination benefited the pediatric
ward as a unit, and not only patients with the specific infec-
tion targeted by the vaccine. We also explored an analysis of
calculating QoC-scores in the non-winter periods expecting no
much of a difference between the pre- and post-vaccination
periods for the 3 patient groups considered and obtaining
much lower scores than during the winter periods. Our
hypothesis was confirmed and indicated a way to validate the
construction of the score-composition. We report these partic-
ular data in the Supplementary Appendix 1.
The analysis can also be used to identify periods of stress by
plotting the daily scores. Our results showed that the daily
Factor 2 (staff management) scores indicated an extended
period of high stress in the winter of 2006, and bed occupancy
indicated an extended period of overcrowding in the winter of
2005. Such information could be used to predict the develop-
ment of problems and to implement remedial actions.
It should be emphasized that this analysis does not support
reductions in personnel numbers in pediatric wards during the
winter period now that rotavirus vaccination has been intro-
duced. Instead, it demonstrates that there was considerable stress
in pediatric wards prior to vaccine introduction. This stress could
have detrimental effects on patients, staff and the efficient opera-
tion of the healthcare system. Introducing the rotavirus vaccine
has reduced the seasonal peak in rotavirus admissions, thus
reducing the winter stress on healthcare services and improving
Table 5. Average QoC scores pre-and post-vaccination for each patient group in winter
Patient group Factor Pre-vaccination Post-vaccination Mean difference t-test p-value (2-tailed)
Overall Factor 1 ¡0.061 0.065 ¡0.127 ¡1.034 0.30
Factor 2 0.514 ¡0.554 1.069 10.332 0.000*
QoC score 0.453 ¡0.488 0.941 5.767 0.000*
Infectious-only Factor 1 0.506 ¡0.546 1.052 10.188 0.000*
Factor 2 ¡0.100 0.108 0.209 ¡1.718 0.087
QoC score 0.406 0.053 0.352 5.107 0.000*
AGE Factor 1 0.501 ¡0.544 1.046 10.125 0.000*
Factor 2 0.333 ¡0.361 0.695 6.152 0.000*
QoC score 0.834 ¡0.906 1.741 11.153 0.000*
AGE, acute gastroenteritis; QoC, quality of care.
*signiﬁcant differences.
Figure 1. Daily Factor 2 (staff management) scores in the winter of 2006
(pre-vaccination) and the winter of 2008 (post-vaccination).
Figure 2. Bed occupancy number per month pre-vaccination and post-
vaccination Footnote: Nbr: number.





























QoC, which should benefit patients, staff and hospital manage-
ment overall. But QoC scores are likely to be dynamic, since they
are composed of several variables, and it is likely that they will
continue to evolve over time.
The technique of EFA to build scores is not new and has espe-
cially been applied in the world of sociology.30 In the medical
world it has been used to help classifying patient-groups in func-
tion of disease severity levels based on scores constructed through
the collection of data from questionnaires.31
Currently, cost-effectiveness analyses of new vaccines have not
been able to include any QoC benefits of vaccination. The pres-
ent analysis offers a way to quantify the QoC benefit, which may
allow its potential impact on hospital costs and quality-adjusted
life-years (QALYs) to be incorporated in economic analyses. We
are exploring this in future research. However we need to be sure
to make links between the level of QoC-scores and the cost of
disease management in hospital care or the impact on QALYs
among the personnel. The latter should preferentially be investi-
gated with prospective data collection. That process doesn’t facil-
itate the implementation of such a study.
The present study has some limitations. First, it was con-
ducted at a single center, and the results should be confirmed in
other settings. We are presently investigating the possibility of
repeating the project in another hospital in Belgium with access
to similar data. However, if we want to expand our research in
other countries it will be difficult. As of today not many countries
in Europe can confirm the analysis results we have as only a few
of them have currently accepted the rotavirus vaccination as a
universal mass vaccination program in children including the
UK, Austria, and Finland. Moreover by limiting the study to one
center in Belgium it was also not possible to include all the varia-
bles we selected for the analysis. For instance we were unable to
introduce nosocomial infection rates which are normally an
appropriate indicator of stress situations in hospital management.
That specific event underwent a dramatic observed reduction
after the introduction of the vaccine. But because of too low
numbers registered during the observation period in this center,
we could not include the variable in the analysis. Another option
to circumvent the problem of too low observation units is to
change the time unit of observation from day to week or months.
This is an option we would like to further explore. Moreover, the
EFA approach remains a subject of debate among experts.32 One
challenging item is about the fitting procedures to obtain the
regression coefficients among the variables and the Factors in
between, called the Factor loadings. Different approaches exist
but there is no method that indicates the best or the worst
approach in calculating these values. In this study here we have
taken a conservative approach by selecting appropriate data and
trying to make the analysis as uniform as possible. Full details are
provided in the Supplementary Appendix 1 to allow other
researchers to replicate the analysis.
Introducing a new vaccine that affects a major public health
problem could have many healthcare benefits beside the improve-
ments of clinical benefits such as mortality and morbidity reduc-
tion. The new vaccine may also unexpectedly have an impact on
other domains of the health care program if that program suffers
as well about overcrowded hospital services during certain peri-
ods, stress in care delivery by health care professionals, bad man-
agement of the beds to be used. These are conditions we often
have difficulties to measure correctly about the deviations of nor-
mal practice. The analysis method here described as EFA has just
the facility to be able to collect that new information quantita-
tively in an easy to apply way and it does not require the collec-
tion of additional data. It integrates several aspects of healthcare
service stress by including both bed-day management and care of
staff, which are linked and should therefore be evaluated
together. The result of such an approach is that we are now in a
position to measure the additional hidden benefit a vaccine can
offer, showing an improved summary score in QoC with better
patient care, more staff time, reduced spread of infectious disease
in hospitals and more resources to apply on other disease areas.
The QoC score can be used to predict periods of stress and iden-
tify problems to tackle during day to day management. Using the
quantitative QoC score may help to find more objective ways of
analyzing the issues of healthcare service stress and the benefit
impact of new interventions.
Methods
Hospital setting
The study was conducted at the Jessa Hospital in Hasselt, Bel-
gium, which is also part of another rotavirus vaccine study.33
Rotavirus vaccination was introduced in the region following the
recommendation of the Flemish High Committee for Public
Health Services (Hoge Gezondheidsraad). The hospital has 34
pediatric beds, and its database was electronically accessible. Its
catchment area was uniform during the study period and there
were no major management changes, allowing comparisons
between pre- and post-vaccination periods. Ethical approval for
the study was obtained in December 2012.
Variables
The hospital’s existing database provided data on the follow-
ing variables relating to management of patient beds and staff,
measured per day that could be used for the construction of the
QoC score:
 Bed-day occupancy number and rate (BDOR): Number of
beds occupied/number of beds available per day;
 Bed-day turnover rate (BTOR): Number of patients dis-
charged/number of beds available per day;
 Unplanned readmission rate (UnPln): Number of readmis-
sions 7 days after discharge/total number of discharges per
day;
 Rotavirus test rate and positive results (RVT): Number of tests
performed per day and rate of positive test results;
 RVGE nosocomial infection rate (RVNR): number of RVGE
nosocomial infections/total number of RVGE hospitalizations
per day
 RVGE specific death rate (RVDR): number of RVGE specific
deaths/total number of RVGE hospitalizations per day





























 Hospitalization rate (HR): number of hospitalizations/total
number of children in the catchment area per day
 Full-time equivalent staff per day (FTE): Total number of
hours worked by the personnel per day/7.6;
 Over-time work by the staff per day (OTW): Total number of
extra hours taken by the personnel/total number of regular
hours per day;
 Sickness leave by the staff per day (SLT): Total number of paid
and unpaid sick days/total number of FTEs per day.
 Staff replacement per day (SR): number of replacement of
staff/total number of staff present per day.
These variables were analyzed descriptively and used to
construct the QoC scores. First, the numbers per day were
assembled to observe whether their distributions were normal.
If not, the data were transformed using log-transformation,
square-root or other methods until a normal or near-normal
distribution was reached. Quintiles were then calculated in 8
groups (5th, 10th, 25th, 50th, 75th, 90th, 95th, >95th) and
each variable value per day was given a score of 1–8 according
to its quintile category. We selected 8 categories in order to
get enough granularity in the spread of the variable values. By
not selecting too few or too many categories it may impact the
analysis with too many empty cells or not enough sensitive
correlation between variables. It should be noted that the end
results (average daily QoC-scores) were analyzed by grouping
period of pre-vaccination and post-vaccination, pooling there-
fore the numbers of several years. We have also split the evalu-
ation period within a year as rotavirus epidemic period or not.
It is expected that the difference in QoC scores are enhanced
if we consider those periods separately instead of a full year
analysis that may dilute the impact with a period where no
difference in results is expected when comparing pre-post vac-
cination in the non-epidemic seasons.
Meanwhile the following variables (RVNR; RVDR; HR;
SR) were deleted from the first analysis. The event numbers
were too small (no deaths and no replacement during the obser-
vation period) or showed no meaningful change over time, so
these variables were not considered further. This was especially
the case for RVNR that with 87 nosocomial infection observa-
tions over a 2557 day period was too low to obtain a meaning-
ful result. Pooling results from different hospitals should
enhance the analysis or considering a shorter time period for
the assessment such as week observations instead of day obser-
vation could have been another approach to circumvent the
obstacle of too few observations. Meanwhile changing the unit
of observation may impact the calculation process when the
data have been collected on a day to day basis. But it is certainly
an option to consider when the analyzing the data of only one
center.
Study period
Data were collected for the period between 1 January 2004
and 31 December 2009, divided into a pre-vaccination period
(before November 2006) and a post-vaccination period (after
November 2006). Winter epidemic months were defined as 1
January to 31 March.
Between 2004 and 2009, there were 2,557 days of which 632
(24.7%) days were during the winter. Of the winter days, 271
(42.9%) days were during the pre-vaccination period and 361
(57.1%) days were during the post-vaccination period. In the
current analysis presented here we only demonstrate the results of
the winter or the rotavirus epidemic period. We did an analysis
of the non-epidemic period as well but that is reported in the
Supplementary Appendix 1.
Patients
The study included data on all patients admitted to the pedi-
atric ward over the study period, stratified into 3 groups:
 Overall population (all admissions);
 Infection-only population (patients admitted for infectious
disease of any kind);
 AGE population (patients in the infection-only group admit-
ted specifically for AGE).
Data analysis
Descriptive
Summary descriptive statistics are reported for each variable
selected for calculating the QoC scores with no statistical signifi-
cance level reported per specific period evaluated for each vari-
able. We did this on purpose as the focus of the study is on the
measurement of the QoC scores and not on the individual vari-
able results used to calculate the QoC scores.
Analytical
A summary QoC score for hospital care should integrate data
from several variables to provide a useful overall measure. Explan-
atory Factor Analysis (EFA)34 is a statistical method that assesses
whether a number of observed variables are linearly related to a
smaller number of unobservable Factors. We used EFA to derive
2 Factors from the observed variables. A scree plot indicated that
only 2 Factors could be constructed from the data. These two
Factors can be summed to produce a summary QoC score if the
Factors are independent from each other. Before conducting the
EFA, the observed data were standardised into 8 quintiles as
described above in order to be able to assemble them correctly
together.
The EFA was conducted in several steps. First, the dataset
was analyzed with specific tests to assess whether EFA can be
applied,35 constructing a correlation matrix for the pairwise
correlation coefficients between the variables. The EFA should
meet 3 objectives: it should be parsimonious (minimum num-
ber of new explanatory Factors created to explain the observed
data); the new Factors should be independent of each other as
far as possible; and the Factor scores should make sense (e.g.,
a Factor score about staff management should be driven by
variables such as overtime and sick leave). Second, the Princi-
pal Component Method (PCM) confirmed that 2 explanatory
Factors could be derived. Third, each Factor was constructed





























with specific factor loadings using varimax rotation because of
the independence of each Factor. Finally, the weighting coeffi-
cient of each variable in the equation that produces the Factor
was adjusted after rotation.
Using the 7 variables listed above, 2 new measures were con-
structed, Factor 1 (bed management) and Factor 2 (staff manage-
ment). The daily score for each Factor was calculated with a
regression equation of all selected variables. The sum of the 2
Factors is the summary QoC score. Higher scores indicate worse
QoC. The Factor scores and QoC scores were compared between
pre- and post-vaccination periods using the T-test, for each
patient group in each season (winter and non-winter). The
P-value cut-off was set at 0.05. All analyses were conducted using
IBM SPSS Statistics v22.0.
Summary results for each Factor and QoC scores are pre-
sented in this paper. A full EFA analysis showing the calculation
of the regression coefficients and Factors for one period (winter)
and one patient group (overall) is provided in the Supplementary
Appendix 1.
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